Human Genetically Engineered Vaccine - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Human Genetically Engineered Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Genetically Engineered Vaccine Market Restraints
Table 3. Human Genetically Engineered Vaccine Market Trends
Table 4. Human Genetically Engineered Vaccine Industry Policy
Table 5. Global Human Genetically Engineered Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Human Genetically Engineered Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Human Genetically Engineered Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Human Genetically Engineered Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Human Genetically Engineered Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Human Genetically Engineered Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Genetically Engineered Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Genetically Engineered Vaccine Manufacturers Product Type
Table 13. Head Office and Human Genetically Engineered Vaccine Production Site of Key Manufacturer
Table 14. Human Genetically Engineered Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Human Genetically Engineered Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Human Genetically Engineered Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Human Genetically Engineered Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Human Genetically Engineered Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Human Genetically Engineered Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Human Genetically Engineered Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Human Genetically Engineered Vaccine Upstream (Raw Materials)
Table 22. Global Human Genetically Engineered Vaccine Typical Customers
Table 23. Human Genetically Engineered Vaccine Typical Distributors
Table 24. By Type, Global Human Genetically Engineered Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Human Genetically Engineered Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Human Genetically Engineered Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Human Genetically Engineered Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Human Genetically Engineered Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Human Genetically Engineered Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Human Genetically Engineered Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Human Genetically Engineered Vaccine Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 36. Pfizer Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Merck Company Information, Head Office, Market Area, and Industry Position
Table 40. Merck Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 41. Merck Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. GSK Company Information, Head Office, Market Area, and Industry Position
Table 45. GSK Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 46. GSK Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. GSK Company Profile and Main Business
Table 48. GSK Recent Developments
Table 49. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information, Head Office, Market Area, and Industry Position
Table 50. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 51. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Profile and Main Business
Table 53. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments
Table 54. Walvax Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 55. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 56. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Walvax Biotechnology Co., Ltd. Company Profile and Main Business
Table 58. Walvax Biotechnology Co., Ltd. Recent Developments
Table 59. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
Table 60. Bharat Biotech Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 61. Bharat Biotech Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bharat Biotech Company Profile and Main Business
Table 63. Bharat Biotech Recent Developments
Table 64. Chengdu Kanghua Biological Products Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 65. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 66. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Chengdu Kanghua Biological Products Co., Ltd. Company Profile and Main Business
Table 68. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
Table 69. South China Vaccine Corporation Limited Company Information, Head Office, Market Area, and Industry Position
Table 70. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 71. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. South China Vaccine Corporation Limited Company Profile and Main Business
Table 73. South China Vaccine Corporation Limited Recent Developments
Table 74. Beijing Health Guard Biotechnology Inc. Company Information, Head Office, Market Area, and Industry Position
Table 75. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 76. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Beijing Health Guard Biotechnology Inc. Company Profile and Main Business
Table 78. Beijing Health Guard Biotechnology Inc. Recent Developments
Table 79. CSL Limited Company Information, Head Office, Market Area, and Industry Position
Table 80. CSL Limited Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 81. CSL Limited Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. CSL Limited Company Profile and Main Business
Table 83. CSL Limited Recent Developments
Table 84. Emergent BioSolutions Company Information, Head Office, Market Area, and Industry Position
Table 85. Emergent BioSolutions Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 86. Emergent BioSolutions Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Emergent BioSolutions Company Profile and Main Business
Table 88. Emergent BioSolutions Recent Developments
Table 89. Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position
Table 90. Sanofi Pasteur Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 91. Sanofi Pasteur Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Sanofi Pasteur Company Profile and Main Business
Table 93. Sanofi Pasteur Recent Developments
Table 94. Serum Institute Company Information, Head Office, Market Area, and Industry Position
Table 95. Serum Institute Human Genetically Engineered Vaccine Models, Specifications, and Application
Table 96. Serum Institute Human Genetically Engineered Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Serum Institute Company Profile and Main Business
Table 98. Serum Institute Recent Developments
List of Figures
Figure 1. Human Genetically Engineered Vaccine Picture
Figure 2. Global Human Genetically Engineered Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Human Genetically Engineered Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Human Genetically Engineered Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Human Genetically Engineered Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Human Genetically Engineered Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Human Genetically Engineered Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Human Genetically Engineered Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Human Genetically Engineered Vaccine Market Share of Global, 2018-2029
Figure 10. Global Human Genetically Engineered Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Human Genetically Engineered Vaccine Key Participants, Market Share, 2022
Figure 12. Global Human Genetically Engineered Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Human Genetically Engineered Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Human Genetically Engineered Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Human Genetically Engineered Vaccine Industry Chain
Figure 16. Human Genetically Engineered Vaccine Procurement Model
Figure 17. Human Genetically Engineered Vaccine Sales Model
Figure 18. Human Genetically Engineered Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Genetic Recombinant Vaccine
Figure 20. Recombinant Subunit Vaccines
Figure 21. Genetic Vaccine
Figure 22. By Type, Global Human Genetically Engineered Vaccine Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Human Genetically Engineered Vaccine Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Human Genetically Engineered Vaccine Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Human Genetically Engineered Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Hepatitis E
Figure 28. Human Papillomavirus (HPV)
Figure 29. Rotavirus
Figure 30. Others
Figure 31. By Application, Global Human Genetically Engineered Vaccine Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Human Genetically Engineered Vaccine Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Human Genetically Engineered Vaccine Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Human Genetically Engineered Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Human Genetically Engineered Vaccine Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Human Genetically Engineered Vaccine Sales Quantity Market Share, 2018-2029
Figure 38. North America Human Genetically Engineered Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Human Genetically Engineered Vaccine Consumption Value Market Share, 2022
Figure 40. Europe Human Genetically Engineered Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Human Genetically Engineered Vaccine Consumption Value Market Share, 2022
Figure 42. Asia Pacific Human Genetically Engineered Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Human Genetically Engineered Vaccine Consumption Value Market Share, 2022
Figure 44. South America Human Genetically Engineered Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Human Genetically Engineered Vaccine Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Human Genetically Engineered Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Human Genetically Engineered Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Human Genetically Engineered Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets